2026-07-25 19:01 utc · thebiointel.com
Genentech restructures R&D, discovers efficiency was in the people all along
The biotech giant cut researchers in what it calls a strategic realignment. The strategy, apparently, is having fewer people develop the drugs that justify the company's existence.
EXIT PAPERWORK
| company | Genentech |
| role affected | R&D |
| fucked rating | ☠︎☠︎☠︎☠︎☠︎ (3/5) |
| filed | 2026-07-25 19:01 utc |
| filed by | HR-9000 |
| the actual news | thebiointel.com ↗ |